Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Clinical NGS panel (human)

PROVIDER: PRJNA889054 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21854867.fastq.gz	Fastqsanger.gz

Items per page:

1 - 1 of 1

Similar Datasets

E-PROT-22

Project description:Panel of 20 human breast cell lines and four clinical tumors

2021-05-25 | E-PROT-22 | ExpressionAtlas

Project description:NGS panel

| PRJNA803819 | ENA

E-GEOD-16237

Project description:Transcription profiling by array of human neuroblastoma patients in two different clinical outcomes

2025-01-24 | E-GEOD-16237 | ExpressionAtlas

Project description:Clinical Exome NGS panel for Hereditary Pheochromocytoma and Paraganglioma diagnosis.

| PRJNA1179733 | ENA

Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants in Myeloid Malignancies: Is It Ready for Prime Time?

Project description:Genetic abnormalities including copy number variants (CNVs, such as gains and losses), and gene mutations are important for diagnosis and treatment of myeloid malignances. In a routine clinical setting, somatic gene mutations are detected by targeted next generation sequencing (NGS), but CNVs are commonly detected by conventional chromosome analysis and fluorescence in situ hybridization (FISH). The aim of this proof-of-principle study was to investigate the feasibility of using a targeted NGS assay to simultaneously detect not only somatic mutations, but also CNVs. Here, we sequenced 406 consecutive patients with myeloid malignancies and performed a head-to-head comparison with the results from conventional clinical assays including conventional chromosome analysis and myeloid FISH to detect CNVs. The targeted NGS assay revealed all 120 CNVs detected by myeloid FISH panel including monosomy 5/5q deletions, monosomy 7/7q deletions, trisomy 8, and 20q deletions. Furthermore, the targeted NGS assay also detected 605 CNVs outsides targeted regions of the myeloid FISH panel, which were revealed by conventional cytogenetic testing. The targeted NGS assay achieved 100% concordance with the myeloid FISH for detection of these common myeloid CNVs, with a high clinical sensitivity (> 99%) and specificity (>99%). The lower limit of detection by the myeloid FISH and the targeted NGS assay was similar and was generally 5% variant allele fraction for DNA. This proof-of-principle study demonstrated that the targeted NGS assay can simultaneously detect both common myeloid CNVs and somatic mutations, which can provide more comprehensive genetic profiling for patients with myeloid malignancies using a single assay.

2021-01-29 | GSE165733 | GEO

E-MEXP-1140

Project description:Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)

2025-01-22 | E-MEXP-1140 | ExpressionAtlas

Next-generation Sequencing of Colorectal Cancer Somatic Cells to Guide Genetic Susceptibility Gene Mutations Screening.

Project description:This is a prospective, single-center, clinical study.This study is to evaluate the feasibility of genetic susceptibility screening based on the detection of tumor tissue mutations by a NGS panel.

| 2330960 | ecrin-mdr-crc

Project description:Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis

| PRJNA927294 | ENA

Project description:Rare Disease Sequencing (NGS, panel)

| PRJNA942436 | ENA

E-GEOD-74000

Project description:Gene expression data from acetaminophen-induced toxicity in human hepatic in vitro systems and clinical liver samples

2025-01-24 | E-GEOD-74000 | ExpressionAtlas